U.S. Food and Drug Administration, Center for Drug Evaluation and Research
FDA Drug Safety Podcasts
Rimani informato con discussioni approfondite sugli aggiornamenti sulla sicurezza dei farmaci e le comunicazioni della FDA, aiutandoti a fare scelte migliori per la tua salute e il tuo benessere.
Serious liver injury being observed in patients without cirrhosis taking Ocaliva (obeticholic acid) to treat primary biliary cholangitis
5 mins • Jan 2, 2025
Charts
- 190NEW
- 177NEW
- 46Decreased by 3
- 108NEW
- 32Decreased by 9
Episodi recenti
Jan 2, 2025
Serious liver injury being observed in patients without cirrhosis taking Ocaliva (obeticholic acid) to treat primary biliary cholangitis
5 mins
Sep 20, 2024
FDA adds warning about rare occurrence of serious liver injury with use of Veozah (fezolinetant) for hot flashes due to menopause
4 mins
Feb 6, 2024
FDA adds Boxed Warning for increased risk of severe hypocalcemia in patients with advanced chronic kidney disease taking osteoporosis medicine Prolia (denosumab)
4 mins
Jan 26, 2024
Update on FDA’s ongoing evaluation of reports of suicidal thoughts or actions in patients taking a certain type of medicines approved for type 2 diabetes and obesity
4 mins
Dec 8, 2023
FDA warns of rare but serious drug reaction to the antiseizure medicines levetiracetam (Keppra, Keppra XR, Elepsia XR, Spritam) and clobazam (Onfi, Sympazan)
5 mins
Lingua
Inglese
Paese
Australia
Sito web
Feed